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Background: Postoperative peritoneal adhesion formation following abdominal surgery remains a relevant surgical
problem. The application of soluble physico-chemical barriers like 4% icodextrin is one approach to protect the
peritoneal surface from getting linked to adhesive scar. The aim of this study was to investigate the influence of
4% icodextrin on peritoneal tissue response both of visceral and parietal peritoneum, adhesion formation and
wound healing.
Methods: 40 rats were divided into two groups. After creation of an intraabdominal defect, either 4% icodextrin
(Adept®) or sodium chloride was applied. Animals were sacrificed after 7 and 21 days. Adhesions were scored by
an adhesion score. Furthermore, immunohistochemical investigations were conducted to determine the discrete
influence of icodextrin on the parietal and visceral peritoneal tissue responses (CD68+ macrophages, CD3+
T-lymphocytes, vimentin for mesenchymal cells, HBME-1 for mesothelial cells, and as components of wound
healing COX-2, C-myc, catenin).
Results: Postoperative peritoneal adhesions were predominantly present in the sodium chloride group as
compared to the icodextrin group (14/19 (74%) vs. 9/19 (47%); p = 0.048). The adhesion score however did not
reveal any significant differences, (p = 0.614). Furthermore, the expression of vimentin in both the parietal and
visceral peritoneum after 21 days was significantly lower in the icodextrin group than in the sodium chloride group
(p = 0.038 and p = 0.028, respectively). No significant differences were observed for macrophages, lymphocytes,
reperitonealisation or the expression of COX-2, C-myc or Catenin.
Conclusions: The intraperitoneal application of 4% icodextrin reduces adhesion formation in comparison to sodium
chloride. 4% icodextrin solution reduces the inflammatory and mesenchymal infiltrate in the wounded area, thus
improving the ratio of mesothel cells to mesenchymal infiltrate. As demonstrated, icodextrin is able to ameliorate the
local tissue response. Further experimental studies would be done to elaborate the impact on the early response of the
adaptive immune system, which may then trigger the subsequent wound healing and tissue repair.
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The formation of postoperative peritoneal adhesions after
abdominal surgery remains a major surgical problem
causing complications like obstipation and ileus [1-3].
Peritoneal adhesion rates higher than 90% after abdominal
surgery have previously been reported [4,5]. Intraabdomi-
nal application of various substances including hyaluronic* Correspondence: cklink@ukaachen.de
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stated.acid/carboxymethylcellulose and 4% icodextrin solution
(Adept®) or systemic application including dimetindene
maleate were used in order to reduce peritoneal adhe-
sions [2,6]. Although in 2007 Brown et al. showed sig-
nificantly reduced adhesion formation of icodextrin in
comparison to lactated Ringer’s solution [7], the effect
of icodextrin remains controversial. Kumar et al. dem-
onstrated that icodextrin has a reductive influence on
adhesion formation, but not on consecutive complications
[8]. Recently, Catena et al. launched the first prospective,
randomized controlled investigation regarding the influenced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 1 cm2 standardised defect zone by scalpel in the
parietal peritoneum of the lateral abdominal wall.
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minal application of icodextrin permits an even distri-
bution. It is assumed to be preserved for 3–5 days after
surgery, during the time of highest risk for adhesion
appearance [10]. Tissue surfaces are kept apart by
flotation offering a sufficient barrier for adhesion forma-
tion [11-13]. So far, no local or systemic side-effects have
been described during metabolism and degradation of
icodextrin [12,14,15].
Defects of appropriate repair mechanisms and per-
sistent inflammatory processes have been described as
potential reasons for adhesion formation [16-18]. The
aim of this study was to determine the impact of
icodextrin on the local tissue response of visceral and
parietal peritoneum in comparison to sodium chloride in
a rat model, and to analyse the potential inflammatory
response markers (CD68, CD3 and COX-2), wound
healing (C-myc, catenin), mesothelium (mesothelial cells)
regeneration and cell integrity (vimentin).
Methods
The experiments were officially approved by the local
Animal Care and Use Review Committee (Landesamt
für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen, AZ8.87-50.10.35.08.319). All animals received
humane care in accordance with the requirements of the
German Animal protection Law, §8 Abs. 1 and in
accordance with the Guide for the Care and Use of
Laboratory Animals published by the National Institute
of Health.
Animals
40 male Wistar rats with a mean bodyweight of 200–
300 g were randomly divided into two groups consisting
of the icodextrin group (n = 20) and the sodium chloride
group (n = 20). All animals were kept under standardized
conditions: temperature between 22°C and 24°C; relative
humidity 50-60%; 12 h of light following 12 h of dark-
ness. The animals had free access to food and water.
Food was withdrawn 12 h before and after surgery. All
operations were carried out under general anesthesia
and aseptic and sterile surgical conditions.
Surgical procedure
Operations were carried out under general anesthesia.
General anesthesia was achieved with a subcutaneous
mixture of 0.3 mg/kg medetomidine (Domitor®, Pfizer
AG, Zurich, Switzerland) and ketamine hydrochloride
100 mg/kg (Ketamin® 10%, Sanofi-Ceva, Düsseldorf,
Germany). A 6 cm midline incision was performed.
After laparotomy, a 1 cm2 standardized defect was cre-
ated in the parietal peritoneum of the left lateral abdo-
minal wall (Figure 1) using a scalpel. Visceral adhesion
induction was performed under sterile conditions usinga standardized abrasion model as previously described
(5 cm proximal of the ileocoecal valve) [10]. The sub-
jects were randomly placed into the different treatment
groups, and either 10 ml/kg of icodextrin 4% (Adept®,
Baxter, USA) or 10 ml/kg of sodium chloride was
administered intraperitoneally. Dosage was assumed from
prior publication [19]. Closure of the fascia was performed
with 3/0 polyglactin continuous sutures (Vicryl®, Ethicon
Inc., Somerville, NJ, USA). Skin closure was subsequently
done with 4/0 polypropylene (Prolene®, Ethicon Inc.,
Somerville, NJ, USA) single sutures. No additional anti-
biotic treatment was given before or during the experi-
ments. Throughout the whole observation period, all
animals underwent daily clinical investigation to assess
local and systemic complications. For exact quantitative
measurement of adhesions, a post mortem examination
was performed. The abdominal cavity was opened using a
U-shaped incision, with its base in the lower abdomen for
complete exploration. The presence of adhesion was re-
gistered. Adhesion score was performed (see below) and
tissue specimens were obtained from the visceral and the
parietal defect in the presence of adhesions, for further
immunohistochemical investigations.Adhesion score
Postoperative peritoneal adhesions were scored by obser-
vers who were blinded to the study groups using an
established adhesion score published by Diamond et al.,
based on extent, type, and tenacity of the adhesion tissue
both for visceral and parietal peritoneum (Table 1) [20].Histological and Immunohistochemical assessment
Histological and immunohistochemical investigations were
performed on paraffin embedded 3 μm sections using
peroxidase-conjugated, affinity-isolated immunoglobulins.
All sections were routinely stained with haematoxylin and
Table 1 Adhesion score by Diamond et al. [20]
Score
Extent
- 0% 0
- < 25% 1
- <50% 2
- <75% 3
- >75% 4
Type
- None 0
- Filmy, no vessels 1
- Opaque, no vessels 2
- Opaque, small vessles 3
- Opaque, large vessels 4
Tenacy
- None 0
- Easily lysed 1
- Lysed with traction 2
- Required sharp dissection 3
Total score 11
Table 2 Evaluation of immunohistochemical results of the
parietal peritoneum depending on the study groups
Day Icodextrin
group
Sodium
chloride group
p-value
CD68 7 1.22 ± 0.44 0.81 ± 0.51 0.218
21 0.78 ± 0.29 0.5 ± 0.5 0.150
CD3 7 0.31 ± 0.24 0.19 ± 0.27 0.321
21 0.17 ± 0.13 0.19 ± 0.17 0.758
Vimentin 7 3 ± 0 3 ± 0 1.000
21 2.31 ± 0.54 2.75 ± 0.66 0.038
Mesothelial cells 7 0.53 ± 0.49 0.61 ± 0.76 0.921
21 2.03 ± 0.88 2.03 ± 0.66 0.689
Mesothelial cells/
Vimentin ratio
7 0.2 ± 0.2 0.2 ± 0.3 0.921
21 0.9 ± 0.4 0.7 ± 0.8 0.539
COX-2 7 0.19 ± 0.17 0.03 ± 0.08 0.018
21 0 0 1.000
C-myc 7 0 0 1.000
21 0.14 ± 0.25 0.03 ± 0.09 0.243
Catenin 7 0.08 ± 0.13 0.06 ± 0.11 0.609
21 0.06 ± 0.11 0.03 ± 0.08 0.539
Data shown are mean ± SD.
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reduce internal staining variations.
Briefly, immunohistochemistry was done according to
the instructions of the manufacturer. CD68+ macrophages
were identified by a 1:50 mouse monoclonal antibody
from Dako (Glostrup, Denmark), pre-treatment of the
fixed specimen with microwave three times, citrate-buffer
pH 6, and as secondary antibody rabbit anti-mouse 1:300
from Dako (Glostrup, Denmark). CD3+ T-lymphocytes
were identified by a 1:50 polyclonal rabbit antibody from
Dako (Hamburg, Germany). Vimentin detection was per-
formed by an anti-vimentin mouse monoclonal antibody
1:100 from Dako, Glostrup, Denmark, pre-treatment of
the fixed specimen with microwave three times, citrate-
buffer pH 6. Mesothelial cells were detected by a ready to
use monoclonal mouse antibody (HBME-1) (Dako,
Glostrup, Denmark). COX-2 detection was carried out by
a 1:100 rabbit monoclonal antibody from DCS (Hamburg,
Germany), pre-treatment microwave three times, citrate-
puffer pH 6, and as secondary antibody goat anti-rabbit
1:300 Dako (Glostrup, Denmark). For the detection of C-
myc we used a 1:50 rabbit polyclonal antibody from Santa
Cruz (California, USA) and as secondary antibody goat
anti-rabbit 1:500 (Dako, Glostrup, Denmark). Catenin was
analyzed by a ready to use rabbit polyclonal antibody
from Spring Bioscience (California, USA) and as secon-
dary antibody goat anti-rabbit 1:500 Dako (Glostrup,
Denmark). The expression of immunohistochemical pa-
rameters was classified by two independent, blinded
observers using a semi-quantitative immunoreactivityscore (IRS). Extent of staining was scored as 0 (0-5%), 1
(5-30%), 2 (30-80%) and 3 (80-100%), indicating the per-
centage of positive stained cells of the area of the section.
Ratio of mesothelial cells to mesenchymal infiltrate
was determined from the data of Table 2 and Table 3,
with expression of vimentin representing the mesenchy-
mal infiltrate.
Statistical analysis
Statistical analysis was carried out using the Statistical
Package for Social Sciences software (SPSS®, Vers.17.0,
Chicago, IL, USA). Appearance of adhesions was tested
with single sided exact Fisher-Test. Differences of the
scores between study groups was analyzed by Kruskal-
Wallis test for non-parametric data. P-values < 0.05 were
considered to be significant. All data are represented as
mean ± standard deviation if not otherwise mentioned.
Results
Two rats died during surgery because of anesthesia com-
plications (one of the icodextrin groups and one of the
sodium chloride groups). After surgical intervention all
other animals returned to normal activity. None of the
rats exhibited local or systemic signs of infection during
the observation period.
Macroscopic evaluation
Adhesion formation was prevalent in the sodium chlor-
ide group than in the icodextrin group (14/19 (74%) vs.
Table 3 Evaluation of immunohistochemical results of the
visceral peritoneum depending on the study groups
Day Icodextrin
group
Sodium
chloride group
p-value
CD68 7 0.7 ± 0.62 0.25 ± 0.25 0.139
21 0.44 ± 0.54 0.47 ± 0.38 0.748
CD3 7 0.03 ± 0.08 0.06 ± 0.11 0.018
21 0.17 ± 0.18 0.33 ± 0.33 0.738
Vimentin 7 2 ± 0.32 2.06 ± 0.39 0.705
21 1.08 ± 0.22 1.31 ± 0.17 0.028
Mesothelial cells 7 1.17 ± 1.02 0.94 ± 1.25 0.293
21 2.33 ± 0.64 2.11 ± 0.66 0.448
Mesothelial cells/
Vimentin ratio
7 0.6 ± 0.5 0.5 ± 0.6 0.921
21 2.2 ± 0.6 1.6 ± 0.4 0.030
COX-2 7 0.7 ± 0.62 0.03 ± 0.08 0.152
21 0.44 ± 0.54 0 1.000
C-myc 7 0.03 ± 0,08 0.03 ± 0.08 0.939
21 0.17 ± 0.18 0.14 ± 0.25 0.457
Catenin 7 0.05 ± 0.11 0.08 ± 0.13 0.521
21 0.06 ± 0.11 0.08 ± 0.13 0.609
Data shown are mean ± SD.
Table 4 Comparison of macroscopical presence of
adhesions and the adhesion score of the icodextrin
group and sodium chloride group depending on the time
period
Icodextrin
group
Sodium
chloride group
p-value
Presence of adhesions
- Day 7 5/10 (50%) 7/10 (70%)
- Day 21 4/9 (44%) 7/9 (78%)
- Total 9/19 (47%) 14/19 (74%) 0.048
Adhesion score
- Day 7
- Visceral peritoneum 2.4 ± 3.4 1.7 ± 2.9 0.544
- Parietal peritoneum 1.6 ± 3.4 2.9 ± 3.2 0.329
- Day 21
- Visceral peritoneum 2.7 ± 3.4 4.3 ± 2.7 0.292
- Parietal peritoneum 0 1.6 ± 2.4 0.066
Data shown are mean ± SD.
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did not show any signs of adhesions macroscopically.
The adhesion score did not reveal significant differences
neither between the two study groups nor between the
two time periods. Results are shown in Table 4.
Microscopic evaluation
After 7 days HE staining revealed an intense formation
of adhesions in the area of the peritoneal trauma. The
defects were filled up with numerous lymphocytes,
plasma cells, macrophages and abundant deposition of
collagen. After 21 days these morphologic observations
presented with a reduced accumulation of these mono-
nuclear cells but increased deposition of collagen.Figure 2 Typical adhesion of the parietal peritoneum after
21 days in the sodium chloride group.Immunohistochemical observations
The immunohistochemical observations were determi-
ned separately for visceral and peritoneal peritoneum.
All findings were evaluated and compared with respect
to time and active agent.
Parietal peritoneum
The immunohistochemical findings of the parietal peri-
toneum are shown in Table 2. In evaluation of CD68 as
a marker of macrophages and monocytes we saw more
CD68+ cells in the icodextrin group than in the sodium
chloride group, however not reaching significance. Over
time the expression decreased significantly in the ico-
dextrin group from day 7 to day 21 (p = 0.021), but not
in the sodium chloride group.
CD3+ T-lymphocytes were constantly seen in both
groups at both time points. Vimentin as a marker of cell
integrity was expressed significantly lower after 21 days
than after 7 days in the idodextrin group (p = 0.002),
being even significantly lower than in the sodium chlo-
ride group at day 21 (p = 0.038).
After 21 days the detection of mesothelial cells showed
a significant elevation in both the icodextrin and the
sodium chloride group (icodextrin group: p = 0.004;
sodium chloride group: p = 0.003), without significant
differences in comparison of the applied agents.
Expression of COX-2 was quite rare in both groups.
However it was significantly higher in the icodextrin
group at day 7 (p = 0.018). After 21 days there was no
longer a positive expression of COX-2 in either group.
Expression of C-myc was negative in both groups at
day 7, though at day 21 there were some positive find-
ings in both groups without any statistical difference.
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The immunohistochemical findings of the visceral peri-
toneum are shown in Table 3. Macrophages were dis-
tributed equally in both groups and at both time points.
Again, the expression of CD3+ T-lymphocytes was gen-
erally comparatively low, however, a significant elevation
of CD3+ T-lymphocytes over the time was observed in
the sodium chloride group but not in the icodextrin
group (p = 0.017, and p = 0.471, respectively).
Vimentin as a marker of cell integrity was expressed
significantly lower after 21 days than after 7 days in both
groups (each p < 0.001). After 21 days the expression
was lower in the icodextrin group than in the sodium
chloride group (p = 0.028).
The detection of mesothelial cells as indicator for
reperitonealisation showed a significant elevation in both
groups over the time (icodextrin group: p = 0.021; sodium
chloride group: p = 0.011). The ratio of mesothelial cells to
mesenchymal infiltrate (vimentin) was significantly eleva-
ted in the icodextrin group in comparison to the sodium
chloride group in (2.2 ± 0.6 vs. 1.6 ± 0.4; p = 0.030).
We observed higher values of COX-2 in the icodextrin
group after 7 days with a marked decrease at day 21
(p = 0.039).
Whereas catenin was rarely expressed in both groups
at both time points, the expression of C-myc showed a
slight increase over time in both study groups, reaching
significance for icodextrin (p = 0.035).Discussion
Injuries to the peritoneum are an inevitable occurrence
during surgery, with an accompanying healing process
which frequently results in the adherence of adjacent
organs by a fibrous mass, commonly denoted as adhe-
sions [5,21]. One attempt to reduce adhesion formation
is the application of bio-absorbable mechanical sub-
stances like icodextrin in order to avoid the agglutin-
ation of the affected organs [4].
Several studies showed a significant reduction of adhe-
sion formation after abdominal surgery due to the applica-
tion of icodextrin [2]. Rodent models are an established
experimental setting in order to simulate human adhesion
formation [18,22]. Aim of this study was to show the
influence of icodextrin on tissue response, adhesion for-
mation and wound healing, of the parietal and visceral
fraction in a rat model.
Some studies describe a significantly positive influence
of icodextrin on the prevention of adhesion formation
others do not [23,24]. A recent prospective randomized
controlled trial of Catena et al. showed that the use of
icodextrin in adhesive small bowel obstruction is safe
and reduces intra-abdominal adhesion formation and
the risk of re-obstruction [9].The current study indicates that icodextrin may func-
tion rather by altering the local repair process than by
acting as a surface barrier. We observed less adhesion in
the peritoneal defect. At both sites the initially enhanced
accumulation of inflammatory and mesenchymal cells in
the icodextrin group almost disappeared over time. This
resulted in an improved ratio of mesothelial cells to
vimentin expression indicating an enhanced reperitoneali-
sation with a reduced mesenchymal scar infiltrate.
Icodextrin might not serve as a simple physico-chemical
barrier just reducing cell activation and invasion. It might
stimulate the local inflammatory defense, and thereby may
trigger the local immunological response resulting in less
scar formation. In this regard our findings suggest the
importance of the initial adaptive immune response to a
trauma for the later balance of scarring and re-
peritonealisation or regeneration. These results provide
further options to prevent adhesions by modifying the
immune response instead of just blocking it.
The identification of macrophages (CD68) and T lym-
phocytes (CD 3) proves an inflammatory activity which
is in accordance with the findings of Binnebösel et al.
who found persistent inflammatory activity in adhesions
even years after initial surgery [16,18]. Hoshino et al. an-
alyzed the importance of the activation of peritoneal
macrophages and their expression of chemokine recep-
tors in promoting post-operative and post-inflammatory
peritoneal adhesion formation [25].
In many studies it has been shown that COX-2 reflects
the inflammatory activity normalizing within weeks after
injury [26-28]. Similarly, we found a close correlation
between appearance of macrophages and expression of
COX-2. We observed low COX-2 expression indicating
a deactivation of the inflammatory situation.
It is generally accepted that vimentin is the major
cytoskeletal component responsible for sustaining cell
integrity, especially found in connective tissue and
smooth muscles [29]. Gonzales et al. demonstrated its
crucial influence on matrix adhesion in endothelial cells
[30]. Nieminen et al. described that vimentin is required
in both the receiving endothelial cell and mononuclear
cell to stabilize endothelial cell interactions [31]. The
decrease of vimentin after 21 days in the study groups
might indicate the incipient reconstitution of cell integ-
rity of the peritoneum. Interestingly, the expression of
vimentin was significantly higher in the parietal periton-
eum than in the visceral peritoneum in both study
groups at both points of time. These findings suggest
that repair mechanisms and restoration of cell integrity
in the parietal peritoneum differs from the visceral periton-
eum. Vimentin as a general marker of mesenchymal cells
may reflect the formation of any scar tissue with fibro-
blasts, endothelial cells and smooth muscle cells [30]. Thus
a higher ratio of mesothelial cell/vimentin expression
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cell layer functions as a natural barrier between the
peritoneal cavity and the adjacent connective tissue [32].
Previous studies demonstrated that the transplantation of
mesothelial cells using intraperitoneal injection is effective
for the prevention of peritoneal adhesions [33,34]. We
found significantly elevated levels of the expression of
mesothelial cells after 21 days in all study groups indicating
the regeneration process of both visceral and parietal
peritoneum.
The C-myc and catenin pathways are known for their
important role in tissue remodelling, wound healing and
regeneration [35,36]. The low expression in our expe-
rimental setting might indicate that the C-myc and
catenin pathways are not appropriate markers in order
to illustrate peritoneal repair mechanisms.
Overall, icodextrin did not induce any signs of
persisting elevated inflammatory reaction in comparison
to the sodium chloride group indicating its excellent bio-
compatibility. Although the adhesion score was not sig-
nificantly lower after icodextrin treatment, our study
revealed a significantly lower presence of adhesion for-
mation in the icodextrin group than in the sodium
chloride group supporting the theory that icodextrin is
capable of reducing adhesion formation, even though
detailed cellular mechanisms are still not comprehended.
One major limitation of our study is the absence of a
control group without peritoneal abrasion or parietal
defect to establish normal values for several immuno-
histochemical parameters. However, the intention was to
simulate repair mechanisms of the visceral and parietal
peritoneum with and without the presence of icodextrin.
Furthermore, conclusions have to be drawn with caution
since results from rodent models cannot be directly
translated to the situation in humans. Further clinical
studies have to demonstrate the definitive effect of
icodextrin on regeneration mechanisms of the visceral
and parietal peritoneum.Conclusions
The intraperitoneal application of 4% icodextrin reduces
adhesion formation in comparison to sodium chloride. 4%
icodextrin solution reduces the inflammatory and mesen-
chymal infiltrate in the wounded area, improving the ratio
of mesothel cells to mesenchymal infiltrate. As here dem-
onstrated, icodextrin is able to ameliorate the local tissue
response. Further experimental studies would elaborate
the impact on the early response of the adaptive immune
system, which then may trigger the subsequent wound
healing and tissue repair.Competing interests
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